Search research articles
Contact Us
Filters
Showing results (591-600 of 621) with videos related to
Page
of 63
Sort By:
Cancers
|
March 25, 2022
Familial Aspects of Mammographic Density Measures Associated with Breast Cancer Risk
Tuong L Nguyen, Shuai Li, James G Dowty, et al.
Cancers
|
June 10, 2022
Genetic Aspects of Mammographic Density Measures Associated with Breast Cancer Risk
Shuai Li, Tuong L Nguyen, Tu Nguyen-Dumont, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 15, 2009
Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation
Daniel S Lorrain, Gretchen Bain, Lucia D Correa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2008
The nuclear membrane organization of leukotriene synthesis
Asim K Mandal, Phillip B Jones, Angela M Bair, et al.
Nature Medicine
|
August 24, 2004
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm
Lei Zhao, Michael P W Moos, Rolf Gräbner, et al.
Rheumatology (Oxford, England)
|
September 29, 1999
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
P Brooks, P Emery, J F Evans, et al.
British Journal of Pharmacology
|
July 24, 2010
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
J S Swaney, C Chapman, L D Correa, et al.
Breast Cancer Research : BCR
|
December 15, 2018
Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds
Tuong L Nguyen, Ye K Aung, Shuai Li, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2011
Sodium [2'-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4'-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): a potent, selective prostaglandin D2 receptor antagonist
Nicholas Stock, Deborah Volkots, Karin Stebbins, et al.
The Journal of Biological Chemistry
|
March 13, 1999
Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity
G Y Ng, J Clark, N Coulombe, et al.
Page
of 63
Search research articles
Search
Showing results (591-600 of 621) with videos related to
Sort By:
Page
of 63
Cancers
|
March 25, 2022
Familial Aspects of Mammographic Density Measures Associated with Breast Cancer Risk
Tuong L Nguyen, Shuai Li, James G Dowty, et al.
Cancers
|
June 10, 2022
Genetic Aspects of Mammographic Density Measures Associated with Breast Cancer Risk
Shuai Li, Tuong L Nguyen, Tu Nguyen-Dumont, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 15, 2009
Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation
Daniel S Lorrain, Gretchen Bain, Lucia D Correa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2008
The nuclear membrane organization of leukotriene synthesis
Asim K Mandal, Phillip B Jones, Angela M Bair, et al.
Nature Medicine
|
August 24, 2004
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm
Lei Zhao, Michael P W Moos, Rolf Gräbner, et al.
Rheumatology (Oxford, England)
|
September 29, 1999
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
P Brooks, P Emery, J F Evans, et al.
British Journal of Pharmacology
|
July 24, 2010
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
J S Swaney, C Chapman, L D Correa, et al.
Breast Cancer Research : BCR
|
December 15, 2018
Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds
Tuong L Nguyen, Ye K Aung, Shuai Li, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2011
Sodium [2'-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4'-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): a potent, selective prostaglandin D2 receptor antagonist
Nicholas Stock, Deborah Volkots, Karin Stebbins, et al.
The Journal of Biological Chemistry
|
March 13, 1999
Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity
G Y Ng, J Clark, N Coulombe, et al.
Page
of 63